Noninvasive quantification of human brain antioxidant concentrations after an intravenous bolus of vitamin C

NMR in Biomedicine

Volumn 24, Issue 5, 2011, Pages 521-528

  Terpstra, Melissa ^a,c   Torkelson, Carolyn ^b   Emir, Uzay ^a   Hodges, James S ^b   Raatz, Susan ^b  

^a UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MINNESOTA   (United States)

^c GRAND FORKS HUMAN NUTRITION RESEARCH CENTER   (United States)

Author keywords

Antioxidants; Ascorbate; Brain; Glutathione; Human; Intravenous; MRS; Noninvasive

Indexed keywords

ANTIOXIDANTS; ASCORBATE; GLUTATHIONES; HUMAN; INTRAVENOUS; MRS; NONINVASIVE;

BLOOD; BRAIN; DISEASES; SODIUM;

VITAMINS;

ANTIOXIDANT; ASCORBIC ACID; GLUTATHIONE;

ADULT; ARTICLE; BRAIN; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; DIET RESTRICTION; DIETARY INTAKE; FEMALE; HOMEOSTASIS; HUMAN; KINETICS; MALE; NON INVASIVE PROCEDURE; OCCIPITAL CORTEX; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; SHAM PROCEDURE; VITAMIN BLOOD LEVEL;

ADULT; ANTIOXIDANTS; ASCORBIC ACID; BRAIN; FEMALE; GLUTATHIONE; HUMANS; INJECTIONS, INTRAVENOUS; MAGNETIC RESONANCE SPECTROSCOPY; MALE;

EID: 79958775142     PISSN: 09523480     EISSN: 10991492     Source Type: Journal    
DOI: 10.1002/nbm.1619     Document Type: Article

References (55)

1. Esposito E, Rotilio D, Di Matteo V, Di Giuliio C, Cacchio M, Algeri S. A review of specific dietary antioxidants and the effects of biochemical mechanisms related to neurodegenerative processes. Neurobiol. Aging, 2002; 23: 719-735.
2. Casetta I, Govoni V, Granieri E. Oxidative stress, antioxidants and neurodegenerative diseases. Curr. Pharm. Des. 2005; 11: 2033-2052.
3. Sonnen JA, Breitner JC, Lovell MA, Markesbery WR, Quinn JF, Montine TJ. Free radical-mediated damage to brain in Alzheimer's disease and its transgenic mouse models. Free Radic. Biol. Med. 2008; 45: 219-230.
4. Halliwell B, Gutteridge JMC. Antioxidants, epidemiology and neurodegenerative disease. In Free Radicals in Biology and Medicine. Oxford University Press: Oxford, 2007; Section 10.5.11, 645-646.
5. 2α excretion is reduced in women by increased vegetable and fruit intake. Am. J. Clin. Nutr. 2005; 82: 768-776.
6. Terpstra M, Marjanska M, Henry P-G, Tkac I, Gruetter R. Detection of an antioxidant profile in the human brain in vivo via double editing with MEGA-PRESS. Magn. Reson. Med. 2006; 56: 1192-1199.
7. Terpstra M, Henry P-G, Gruetter R. Measurement of reduced glutathione (GSH) in human brain using LCModel analysis of difference-edited spectra. Magn. Reson. Med. 2003; 50: 19-23.
8. 1H NMR spectroscopy at 4T: application to schizophrenia. Magma, 2005; 18: 276-282.
9. 1H NMR detection of vitamin C in human brain in vivo. Magn. Reson. Med. 2004; 51: 225-229.
10. 1H MRS. Magn. Reson. Med. 2006; 55: 979-983.
11. Emir U, Deelchand D, Henry P-G, Terpstra M. Simultaneous quantitation of T2 and concentration of ascorbate and glutathione in the human brain from the same double edited spectra. NMR Biomed. 2010; in press.
12. Rice ME, Russo-Menna I. Differential compartmentalization of brain ascorbate and glutathione between neurons and glia. Neuroscience, 1998; 82: 1213-1223.
13. Jacob RA. The integrated antioxidant system. Nutr. Res. 1995; 15: 755-766.
14. Heideger MA. New view at C. Nat. Med. 2002; 8: 445-446.
15. Huang J, May JM. Ascorbic acid spares alpha-tocopherol and prevents lipid peroxidation in cultured H4IIE liver cells. Mol. Cell Biochem. 2003; 247: 171-176.
16. Kitazawa M, Podda M, Thiele J, Traber M, Iwasaki K, Sakamoto K, Packer L. Interactions between vitamin E homologues and ascorbate free radicals in murine skin homogenates irradiated with ultraviolet light. Photochem. Photobiol. 1997; 65: 355-365.
17. Harrison FE, May JM. Vitamin C function in the brain: vital role of the ascorbate transporter SVCT2. Free Radic. Biol. Med. 2009; 46: 719-730.
18. Dietary Reference Intakes for Vitamin C, Vitamin E, Selenium and Carotenoids. Food and Nutrition Board, Institute of Medicine of the National Academies: Washington DC, 2000.
19. Kallner A, Hartmann D, Hornig D. Steady-state turnover and body pool of ascorbic acid in man. Am. J. Clin. Nutr. 1979; 32: 530-539.
20. Padayatty SJ, Sun H, Wang Y, Riordan HD, Hewitt SM, Kalz A, Wesley RA, Levine M. Vitamin C pharmacokinetics: implications for oral and intravenous use. Ann. Intern. Med. 2004; 140: 533-537.
21. Riordan HD, Hunninghake RB, Riordan NH, Jackson JJ, Meng X, Taylor P, Casciari JJ, Gonzales MJ, Miranda-Massari JR, Mora EM, Rosario N, Rivera A. Intravenous ascorbic acid: protocol for its application and use. P.R. Health Sci. J. 2003; 22: 287-290.
22. Terpstra M, Andersen PM, Gruetter R. Localized eddy current compensation using quantitative field mapping. J. Magn. Reson. 1998; 131: 139-143.
23. Adriany G, Gruetter R. A half-volume coil for efficient proton decoupling in humans at 4 Tesla. J. Magn. Reson. 1997; 125: 178-184.
24. Czosnyka M, Czosnyka Z, Momjian S, Picakrd JD. Cerebrospinal fluid dynamics. Physiol. Meas. 2004; 25: R51-R76.
25. Gruetter R, Tkac I. Field mapping without reference scan using asymmetric echo-planar techniques. Magn. Reson. Med. 2000; 43: 319-323.
26. 1H NMR spectroscopy of rat brain at 1ms echo time. Magn. Reson. Med. 1999; 41: 649-656.
27. Mescher M, Merkle H, Kirsch J, Garwood M, Gruetter R. Simultaneous in vivo spectral editing and water suppression. NMR Biomed. 1998; 11: 266-272.
28. 1H spectra with LCModel. NMR Biomed. 2001; 14: 260-264.
29. Govindaraju G, Young K, Maudsley A, Proton, NMR chemical shifts and coupling constants for brain metabolites. NMR Biomed. 2000; 13: 129-153.
30. Henry P, Marjanska M, Walls J, Valette J, Gruetter R, Ugurbil K. Proton-observed carbon-edited NMR spectroscopy in strongly coupled second-order spin systems. Magn. Reson. Med. 2006; 55: 250-257.
31. 1H metabolite resonances at long TE. Magn. Reson. Med. 2005; 53: 1283-1287.
32. 2 measurement and quantification of glutamate in human brain in vivo. Magn. Reson. Med. 2006; 56: 971-977.
33. Rice ME. Ascorbate regulation and its neuroprotective role in the brain. Trends Neurosci. 2000; 23: 209-216.
34. Spector R, Johanson C. Micronutrient and urate transport in choroid plexus and kidney: implications for drug therapy. Pharm. Res. 2006; 23: 2515-2524.
35. 131I]iodo-L-ascorbic acid for the in vivo study of ascorbate: autoradiography, biodistribution in normal and hypolipidemic rats, and in tumor-bearing nude mice. Biol. Pharm. Bull. 2009; 32: 1906-1911.
36. +-dependent L-ascorbic acid transporters. Nature, 1999; 399: 70-75.
37. Spector R. Nutrient transport systems in brain: 40 years of progress. J. Neurochem. 2009; 111: 315-320.
38. Tveden-Nyborg P, Johansen LK, Riada Z, Villumsen CK, Larsen JO, Lykkesfeldt J. Vitamin C deficiency in early postnatal life impairs spatial memory and reduces the number of hippocampal neurons in guinea pigs. Am. J. Clin. Nutr. 2009; 90: 540-546.
39. Levine M, Conry-Cantilena C, Wang Y, Welch RW, Washko PW, Dhariwal KR, Park JB, Lazarev A, Graumlich JF, King J, Cantilena LR. Vitamin C pharmacokinetics in healthy volunteers: evidence for a recommended dietary allowance. Proc. Natl. Acad. Sci. USA, 1996; 93: 3704-3709.
40. Reiber H, Ruff M, Uhr M. Ascorbate concentration in human cerebrospinal fluid (CSF) and serum. Intrathecal accumulation and CSF flow rate. Clin. Chim. Acta, 1993; 217: 163-173.
41. Serot J-M, Bene M-C, Faure GC. Choroid plexus, ageing of the brain, and Alzheimer's disease. Front. Biosci. 2003; 8: S515-S521.
42. Sotiriou S, Gispert S, Cheng J, Wang Y, Chen A, Hoogstraten-Miller S, Miller GF, Kwon O, Levine M, Guttentag SH, Nussbaum RL. Ascorbic-acid transporter Slc23a1 is essential for vitamin C transport into the brain and for perinatal survival. Nat. Med. 2002; 8: 514-517.
43. Harrison FE, Hosseini AH, McDonald MP, May JM. Vitamin C reduces spatial learning deficits in middle-aged and very old APP/PSEN1 transgenic and wild-type mice. Pharmacol. Biochem. Behav. 2009; 93: 443-450.
44. Qui S, Li L, Weeber EJ, May JM. Ascorbate transport by primary cultured neurons and its role in neuronal function and protection against excitotoxicity. J. Neurosci. Res. 2007; 85: 1046-1056.
45. Harrison FE, Yu SS, Van Den Bossche KL, Li L, May JM, McDonald MP. Elevated oxidative stress and sensorimotor deficits but normal cognition in mice that cannot synthesize ascorbic acid. J. Neurochem. 2008; 106: 1198-1208.
46. Dai Q, Borenstein AR, Wu Y, Jackson JC, Larson EB. Fruit and vegetable juices and Alzheimer's disease: the Kame project. Am. J. Med. 2006; 119: 751-759.
47. Rengachary SS, Ellenbogen RS. (eds). Principles of Neurosurgery. Elsevier Mosby: Edinburgh, 2005.
48. Hrabetova S, Nicholson C. Contribution of dead-space microdomains to tortuosity of brain extracellular space. Neurochem. Int. 2004; 45: 467-477.
49. Flaring UB, Hebert C, Wernerman J, Hammarqvist F, Rooyackers OE. Circulating and muscle glutathione turnover in human endotoxaemia. Clin. Sci. 2009; 117: 313-319.
50. Kyparos A, Vrabas IS, Nikolaidis MG, Riganas CS, Kouretas D. Increased oxidative stress blood markers in well-trained rowers following two thousand-meter rowing ergometer race. J. Strength Cond. Res. 2009; 23: 1418-1426.
51. Elverfeldt DV, Buechert M, Kaufmann R, Huell M, Hennig J. Evidence for detection of ascorbic acid in the human brain at 3T. Proceedings of the 14th Annual Meeting ISMRM. Seattle, WA, USA, 2006; 3145.
52. 1H spectroscopy using a clinical 3T MR system: detectability and reliability within the human brain. J. Magn. Reson. Imaging, 2008; 28: 351-358.
53. 1H NMR spectroscopy of the human brain at high magnetic fields: metabolite quantification at 4T vs7T. Magn. Reson. Med. 2009; 62: 868-879.
54. 1H NMR spectroscopy at 7 T. NMR Biomed. 2010; 23: 227-232.
55. 1H MRS in human brain at 7 T. Magn. Reson. Mater. Phys. 2009; 22: 1-4.